Page 100 - Read Online

Thomas et al. J Transl Genet Genom 2024;8:249-77 https://dx.doi.org/10.20517/jtgg.2024.15 Page 277

278. Huber ML, Haynes L, Parker C, Iversen P. Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate
cancer. J Natl Cancer Inst 2012;104:273-9. DOI PubMed PMC
279. Murphy G, Tjoa B, Ragde H, Kenny G, Boynton A. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic
cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 1996;29:371-80. DOI PubMed
280. Tjoa B, Erickson S, Bowes V, et al. Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed
with PSMA peptides. Prostate 1997;32:272-8. DOI
281. Jähnisch H, Füssel S, Kiessling A, et al. Dendritic cell-based immunotherapy for prostate cancer. Clin Dev Immunol
2010;2010:517493. DOI PubMed PMC
282. Kiessling A, Wehner R, Füssel S, Bachmann M, Wirth MP, Schmitz M. Tumor-associated antigens for specific immunotherapy of
prostate cancer. Cancers 2012;4:193-217. DOI PubMed PMC
283. Kitamura H, Torigoe T, Asanuma H, Honma I, Sato N, Tsukamoto T. Down-regulation of HLA class I antigens in prostate cancer
tissues and up-regulation by histone deacetylase inhibition. J Urol 2007;178:692-6. DOI PubMed
284. Lozano M, Cid J, Benitez-Ribas D, Otero MJ. Technical challenges in the manufacture of dendritic cell cancer therapies. Eur Oncol
Haematol 2019;15:22-8. DOI
285. Kongsted P, Borch TH, Ellebaek E, et al. Dendritic cell vaccination in combination with docetaxel for patients with metastatic
castration-resistant prostate cancer: a randomized phase II study. Cytotherapy 2017;19:500-13. DOI
286. Glabman RA, Choyke PL, Sato N. Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy. Cancers
2022;14:3906. DOI PubMed PMC
287. Boudewijns S, Westdorp H, Koornstra RH, et al. Immune-related adverse events of dendritic cell vaccination correlate with
immunologic and clinical outcome in stage III and IV melanoma patients. J Immunother 2016;39:241-8. DOI PubMed PMC
288. Agrawal A, Sridharan A, Prakash S, Agrawal H. Dendritic cells and aging: consequences for autoimmunity. Expert Rev Clin Immunol
2012;8:73-80. DOI PubMed PMC